AbStrAct. the metabolic syndrome is characterized by a cluster of related clinical, anthropometric and biochemical features such as central obesity, dysglycaemia, dyslipidaemia and hypertension. It is highly prevalent in the general population (approximately 22%), with differences in relation to race, gender, and age. It carries an increased cardiovascular morbidity and mortality, which makes an early and correct assessment mandatory. the prevalence of the metabolic syndrome is very high in type 2 diabetes patients, in whom it influences the risk of chronic complications. the aim of the present report is to explore the characteristics and the combination types of the metabolic syndrome and to assess the cardiovascular risk in patients presenting this clinical entity. 329 patients consecutively diagnosed with metabolic syndrome were included in the study, both men and women, no limit regarding age. Tomitana -2012; 4(71) DOI 10.2478/v10307-012-0036-4 188 -192 metabolic syndrome was the rarest, less than 25% of the patients presenting all 5 definition criteria and it was more frequent among men (men 39.2% vs women 15.9%: p < 0.0001). Apart from central obesity, which is mandatory for diagnosing MetS and thus present in all patients, arterial hypertension is the most common finding in our study population, with impaired glycaemia and increased triglycerides occupying the second and third place, respectively. central obesity, arterial hypertension and impaired glycaemia represent the most frequent combination, a real "hard core" of MetS.
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AbStrAct. the metabolic syndrome is characterized by a cluster of related clinical, anthropometric and biochemical features such as central obesity, dysglycaemia, dyslipidaemia and hypertension. It is highly prevalent in the general population (approximately 22%), with differences in relation to race, gender, and age. It carries an increased cardiovascular morbidity and mortality, which makes an early and correct assessment mandatory. the prevalence of the metabolic syndrome is very high in type 2 diabetes patients, in whom it influences the risk of chronic complications. the aim of the present report is to explore the characteristics and the combination types of the metabolic syndrome and to assess the cardiovascular risk in patients presenting this clinical entity. 329 patients consecutively diagnosed with metabolic syndrome were included in the study, both men and women, no limit regarding age. Patient selection was made during the periodic medical visits in the outpatient clinics of Diabetes, Cardiology and Internal Medicine. Metabolic syndrome (MetS) was diagnosed according to 2005 International Diabetes Federation (IDF) criteria. Women were more frequent than men, mean age was 59.08±888 and they all had central obesity (it is the major criteria of 2005 IDF definition for MetS) .The diagnosis of the metabolic syndrome was fulfilled with only 3 criteria, most of the times. the complete 1 metabolic syndrome was the rarest, less than 25% of the patients presenting all 5 definition criteria and it was more frequent among men (men 39.2% vs women 15.9%: p < 0.0001). Apart from central obesity, which is mandatory for diagnosing MetS and thus present in all patients, arterial hypertension is the most common finding in our study population, with impaired glycaemia and increased triglycerides occupying the second and third place, respectively. central obesity, arterial hypertension and impaired glycaemia represent the most frequent combination, a real "hard core" of MetS.
As expected, the cardiovascular risk was high in the study population. the cardiovascular "score" of our patients increased significantly with the number of components used for the diagnosis of MetS (MetS with 3 elements vs MetS with 4 elements vs MetS with 5 elements: ScOrE -5.36 ± 7.07 vs 7.66 ± 8.63 vs 8.52 ± 8.34, p < 0.01).
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Background
Almost 250 years ago, the Italian anatomist Morgagni demonstrated the frequent association between central obesity, atherosclerosis and gout. In 1923, Kylin also emphasized the morbid association between arterial hypertension, diabetes mellitus and gout [1] . Later, in 1950, French doctor J. Vague observed that very often individuals with central obesity had in the same time type 2 diabetes mellitus and/or cardiovascular diseases [1] . then, 15 years later, Avogaro and crepaldi implemented the concept of "plurimetabolic syndrome" which included obesity, dyslipidemia, arterial hypertension and diabetes mellitus [1] .
the true history of the metabolic syndrome (MetS) starts after 1988. That year, at the event called "banting Lectures", Gerry reaven had a conference about what he called at that time "X syndrome", a clinical entity composed of dysglycaemia, dyslipidemia, obesity and arterial hypertension [2, 3] .
Grouping all these diseases under a new larger concept was necessary considering the fact that X syndrome patients had a major cardiovascular risk, higher than that resulted by simply summation of composite risks. that is why, in 1989, Kaplan refers to this syndrome using the term "killer quartet" [4] .
the most frequent term used nowadays is "metabolic syndrome". However, not only for semantic reasons, the proper term to use would be "dysmetabolic syndrome" [5] .
The great number of definitions and diagnosis criteria along with the heterogeneity of studied populations make the metabolic syndrome (MetS) concept a difficult one from epidemiological point of view. recent data show the pandemic character of the syndrome:
• 1 out of 4 adults has MetS and among old patients (age over> 60 years) the prevalence rises up to 40% [6] ; • an increased prevalence (nearly 20%) observed among children and adolescents [7, 8] ;
Aim of study the aim of the present report is to explore the characteristics and the combination types of the metabolic syndrome and to assess the cardiovascular risk in patients presenting this clinical entity.
Materials and Methods
We conducted a clinical study over a five years period (2005 -2010), which included 329 patients consecutively diagnosed with metabolic syndrome, both men and women, no limit regarding age. 
Figure 1 -Distribution according to the number of MetS elements
Analyzing the whole study population, we observed that most of the men already have the complete metabolic syndrome before they reached 60 ; in contrast, in women, the complete syndrome was the rarest configuration and it seems that age doesn't play a decisive part in the number of components. The three types of MetS may result, through permutations of definition elements, into 11 possible variants. In our study population, the most frequent one was that in which all the 5 criteria were met, followed by the combinations of arterial hypertension with impaired glycaemia and/or increased triglycerides. the rarest combination was the association between low HDL-cholesterol and impaired glycaemia.
The so called complete MetS was more frequent among men (men 39.2% vs women 15.9%: p < 0.0001). the most frequent combinations with 3 and 4 components, respectively, were especially seen in women (arterial hypertension + impaired glycaemia: women 20.7% vs men 8.8%; p < 0.0001 and arterial hypertension + impaired glycaemia + increased triglycerides: women 20.3% vs men 7.8%; p < 0.0001). the cardiovascular risk was calculated using Conroy's modified SCORE diagram (the risk is two fold in the presence of diabetes mellitus). As expected, the cardiovascular risk was high in the study population. 
Figure 2.Distribution according to cardiovascular risk class
Analyzing the study population by gender, we observed that men dominated the group with high cardiovascular risk, the difference from women reaching the statistical significance (SCORE > 5: women 43.2% vs men 71.6%, p < 0.0001; medium ScOrE -women 5.62 ± 6.20 vs men 9.90 ± 10.60, p < 0.0001). these results were not so predictable because in our study population, although more men were affected by diabetes and were smoking, the female patients were older and more frequently had arterial hypertension and/or high cholesterol levels. 
Conclusions
Apart from central obesity, which is mandatory for diagnosing MetS and thus present in all patients, arterial hypertension is the most common finding in our study population, with impaired glycaemia and increased triglycerides occupying the second and third place, respectively. Finally, the rarest finding in this group was the low HDL-cholesterol level.
Most of the times, only three criteria were sufficient for diagnosing MetS, while the "complete" MetS was the rarest.
central obesity, arterial hypertension and impaired glycaemia represent the most frequent combination, a real "hard core" of MetS.
The cardiovascular risk associated with MetS increases significantly with the number of components used/fulfilled/met for diagnosis.
